Revive Therapeutics CSE: RVV | OTC: RVVTF Revive Therapeutics is focused on the R&D and sale of cannabinoid-based products, recently expanding into the psychedelics industry more broadly. Revive Therapeutics$0.4850-4.90%$0.0200 Latest News Revive Therapeutics Announces Filing of a Pre-CTA Meeting Request with Health Canada and Update on U.S. FDA IND Filing and Phase 3 Clinical Trial Design for Bucillamine in the Treatment of COVID-19 June 3, 2020 Revive Therapeutics Provides Corporate Update on its Pharmaceutical Initiatives May 13, 2020 Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program April 29, 2020 Join our Newsletter Get the latest Company updates delivered to straight to your inbox. Leave this field empty if you're human: